, Tracking Stock Market Picks
Enter Symbol:
AbbVie (ABBV) [hlAlert]

up 81.51 %

AbbVie (ABBV) rated Outperform by Wells Fargo

Posted on: Wednesday,  Jan 16, 2013  8:25 AM ET by Wells Fargo

Wells Fargo rated Outperform AbbVie (NYSE: ABBV) on 01/16/2013, when the stock price was $35.54. Since
then, AbbVie has gained 81.51% as of 12/01/2015's recent price of $64.51.
If you would have followed this Wells Fargo's recommendation on ABBV, you would have gained 81.51% of your investment in 1049 days.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/16/2013 8:25 AM Buy
as of 12/13/2013
1 Week up  1.98 %
1 Month up  9.44 %
3 Months up  16.66 %
1 YTD up  47.35 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy